Zusammenfassung: Im Jahr 2010 wurden in Deutschland insgesamt dreiundzwanzig Arzneimittel mit neuen Wirkstoffen eingef\u00fchrt, also weniger als 2009. F\u00fcnf haben eine innovative Struktur bzw. ein neuartiges Wirkprinzip mit therapeutischer Relevanz (Kategorie A nach Fricke; s. Tab. 1). Bei neun besteht eine Verbesserung pharmakodynamischer oder pharmakokinetischer Wirkprinzipien. Zehn sind Analogpr\u00e4parate ohne wesentliche Vorteile und bei einem […]<\/p>\n","protected":false},"excerpt":{"rendered":"
Zusammenfassung: Im Jahr 2010 wurden in Deutschland insgesamt dreiundzwanzig Arzneimittel mit neuen Wirkstoffen eingef\u00fchrt, also weniger als 2009. F\u00fcnf haben eine innovative Struktur bzw. ein neuartiges Wirkprinzip mit therapeutischer Relevanz (Kategorie A nach Fricke; s. Tab. 1). Bei neun besteht eine Verbesserung pharmakodynamischer oder pharmakokinetischer Wirkprinzipien. Zehn sind Analogpr\u00e4parate ohne wesentliche Vorteile und bei einem […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[185,1076,2491,3593,1733,1732,184,2763,255,3595,3588,3594,3592,468,466,799,3589,471,3587,840,3383,3590,2627,3591,2764,15,3601,187,3600,2513,245,242,1107,1455,2838,249,3598,3602,248,257,1502,1499,1498,3603,1149,1177,2145,3604,2956,2957,70,3596,2246,795,794,793,2210,786,792,1504,3597,1090,3599,1467,183,3459,754,2137,753,8,3583,2140,3582,96,97,803,802,3585,3586,3584,2136,181],"class_list":["post-1527","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-absolute-arrhythmie","tag-akute-myeloische-leukaemie","tag-allergische-rhinitis","tag-amifampridin","tag-angioneurotisches-oedem","tag-angiooedem","tag-arrhythmien","tag-arthritis-urica","tag-arzneimittel","tag-asenapin","tag-bazedoxifen","tag-bilastin","tag-bipolare-stoerung","tag-chronisch-obstruktive-lungenerkrankung","tag-chronische-bronchitis","tag-chronische-lymphatische-leukaemie","tag-conestat-alfa","tag-copd","tag-corifollitropin-alfa","tag-denosumab","tag-dronedaron","tag-eltrombopag","tag-febuxostat","tag-fruchtbarkeit","tag-gicht","tag-graviditaet","tag-hereditaeres-angiooedem","tag-herzrhythmusstoerungen","tag-histamin","tag-hyperurikaemie","tag-idiopathische-thrombozytopenische-purpura","tag-immunthrombozytopenie","tag-impfstoffe","tag-impfung","tag-indacaterol","tag-itp","tag-lambert-eaton-myasthenie","tag-m-gaucher","tag-m-werlhof","tag-medikamente","tag-meningokokken","tag-meningokokken-meningitis","tag-meningokokkenmeningitis","tag-mifamurtid","tag-neuroleptika","tag-nierenzellkarzinom","tag-obstipation","tag-ofatumumab","tag-orphan-drugs","tag-orphan-arzneimittel","tag-osteoporose","tag-osteosarkom","tag-pazopanib","tag-pneumokokken","tag-pneumokokken-impfstoff","tag-pneumokokken-impfung","tag-pneumokokken-meningitis","tag-pneumokokkenimpfstoff","tag-pneumokokkenimpfung","tag-pneumokokkenmeningitis","tag-polyvalenter-pneumokokken-impfstoff","tag-prostatahyperplasie","tag-prucaloprid","tag-rhinitis","tag-rhythmusstoerungen","tag-roflumilast","tag-schmerzen","tag-schmerzmittel","tag-schmerztherapie","tag-schwangerschaft","tag-silodosin","tag-tapentadol","tag-tetravalenter-meningokokken-impfstoff","tag-thrombopenie","tag-thrombozytopenie","tag-tyrosinkinase-hemmer","tag-tyrosinkinase-inhibitoren","tag-urtikaria","tag-velaglucerase-alfa","tag-vernakalant","tag-verstopfung","tag-vorhofflimmern"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1527"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1527\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}